Adipose-derived stem cell transplantation for therapeutic lymphangiogenesis in a mouse secondary lymphedema model.

Abstract:

AIM:Secondary lymphedema is observed in common after postmalignancy treatment of the breast and the gynecologic organs but effective therapies are not established. Adipose-derived stem cells (ADSCs), which are pluripotent, regenerative in local injection, are tested for murine hindlimb secondary lymphedema by regenerative method. METHODS & RESULTS:Mice were divided into four groups: no ADSCs, 1 × 10(6) ADSCs, 1 × 10(5) ADSCs and 1 × 10(4) ADSCs (each group, n = 20) in a stringent surgical resection and irradiation. Circumferential measurement, lymphatic flow assessment and quantification of lymphatic vessels were performed. RESULTS:The numbers of lymphatic vessels by LYVE-1 immunohistochemistry, and VEGF-C- or VEGFR3-expressing cells were significantly increased in transplanted groups (p < 0.05). CONCLUSION:ADSCs can restore the lymphatic vascular network in secondary lymphedema with increased collecting vessels.

journal_name

Regen Med

journal_title

Regenerative medicine

authors

Yoshida S,Hamuy R,Hamada Y,Yoshimoto H,Hirano A,Akita S

doi

10.2217/rme.15.24

subject

Has Abstract

pub_date

2015-01-01 00:00:00

pages

549-62

issue

5

eissn

1746-0751

issn

1746-076X

journal_volume

10

pub_type

杂志文章
  • In vitro potential of human mesenchymal stem cells for corneal epithelial regeneration.

    abstract::Aim: To determine the potential of mesenchymal stem cells (MSC) for corneal epithelial regeneration in vitro. Materials & methods: Bone marrow MSC (BM-MSC) and adipose tissue MSC were analyzed for corneal epithelial and mesenchymal markers, using limbal stem cells and corneal cells as controls. MSC with better potenti...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0067

    authors: Nieto-Nicolau N,Martín-Antonio B,Müller-Sánchez C,Casaroli-Marano RP

    更新日期:2020-03-01 00:00:00

  • Industry updates from the field of stem cell research and regenerative medicine in March 2020.

    abstract::Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions in March 2020. ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0052

    authors: Ilic D,Liovic M

    更新日期:2020-07-01 00:00:00

  • A panel of tests to standardize the characterization of human embryonic stem cells.

    abstract::Human embryonic stem cells offer a renewable source of a wide range of cell types for use in research and cell-based therapies. Characterizing these cells provides important information about their current state and affords relevant details for subsequent downstream manipulation. Prior to considering therapeutic appli...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.2.179

    authors: Pal R,Mandal A,Rao HS,Rao MS,Khanna A

    更新日期:2007-03-01 00:00:00

  • Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.

    abstract::Multipotent mesenchymal stromal cells (MSCs) hold tremendous promise for tissue engineering and regenerative medicine, yet with so many sources of MSCs, what are the primary criteria for selecting leading candidates? Ideally, the cells will be multipotent, inexpensive, lack donor site morbidity, donor materials should...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.10.98

    authors: Wang L,Ott L,Seshareddy K,Weiss ML,Detamore MS

    更新日期:2011-01-01 00:00:00

  • Reparative medicine: from tissue engineering to joint surface regeneration.

    abstract::Biological regeneration is proving to be an increasingly attractive alternative/complement to prosthetic replacement of tissues and organs. In cell-based therapeutic approaches, cells are manipulated in vitro and administered to patients as living and dynamic biological agents. In this review, we have focused on the r...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.1.1.59

    authors: De Bari C,Pitzalis C,Dell'Accio F

    更新日期:2006-01-01 00:00:00

  • Methods and practices to diversify cell-based products.

    abstract::Medicinal signaling cell (MSC)-based products represent emerging treatments in various therapeutic areas including cardiometabolic, inflammation, autoimmunity, orthopedics, wound healing and oncology. Exploring innovation beyond minimally manipulated plastic-adherent ex vivo expanded allogeneic MSCs enables product de...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0093

    authors: Vertès AA

    更新日期:2017-12-01 00:00:00

  • The olfactory mucosa: a potential source of stem cells for hearing regeneration.

    abstract::The olfactory mucosa contains cells that enable it to generate new neurons and other supporting cells throughout life, allowing it to replace cells of the mucosa that have been damaged by exposure to various insults. In this article, we discuss the different types of stem cell found within the olfactory mucosa and the...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2018-0009

    authors: Young E,Westerberg B,Yanai A,Gregory-Evans K

    更新日期:2018-07-01 00:00:00

  • Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.

    abstract::In June 2013, the US Supreme Court ruled that naturally occurring genes were unpatentable in the case Association for Molecular Pathology v. Myriad Genetics. Up until this decision, Myriad Genetics was the only company in the USA that could legally conduct diagnostic testing for BRCA1 and 2, genes that are linked to f...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.93

    authors: Matthews KR,Cuchiara ML

    更新日期:2014-03-01 00:00:00

  • The past, present and future of ligament regenerative engineering.

    abstract::Regenerative engineering has been defined as the convergence of Advanced Materials Sciences, Stem Cell Sciences, Physics, Developmental Biology and Clinical Translation for the regeneration of complex tissues and organ systems. Anterior cruciate ligament (ACL) reconstruction necessitates the regeneration of bone, liga...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0125

    authors: Mengsteab PY,Nair LS,Laurencin CT

    更新日期:2016-12-01 00:00:00

  • Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice.

    abstract::Inflammation plays a critical role in the secondary degenerative response to spinal cord injury (SCI). The influx of inflammatory cells following SCI is preceded by the expression of specific chemoattractants, including chemokines. The chemokine CXCL10 is a potent T lymphocyte recruiter and has been strongly implicate...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.5.771

    authors: Gonzalez R,Hickey MJ,Espinosa JM,Nistor G,Lane TE,Keirstead HS

    更新日期:2007-09-01 00:00:00

  • Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.

    abstract:AIM:To evaluate the in vitro immunogenic and immunomodulatory properties of induced pluripotent stem cells (iPSCs) compared with bone marrow-derived mesenchymal stromal cells (MSCs). MATERIALS & METHODS:Mouse embryonic fibroblasts (MEFs) were isolated from C3HeB/FeJ and C57BL/6J mice, and reprogrammed to generate iPSC...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.14.29

    authors: Schnabel LV,Abratte CM,Schimenti JC,Felippe MJ,Cassano JM,Southard TL,Cross JA,Fortier LA

    更新日期:2014-01-01 00:00:00

  • Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.

    abstract:AIM:Dendritic cell (DC)-based vaccines have a potential utility for use in the treatment of malignancy. Human embryonic stem cells (hESCs) may provide a more cost-effective and reliable source of DCs for immunotherapy purposes, providing on-demand access for patients. METHOD:We developed a protocol to generate DCs fro...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.09.25

    authors: Tseng SY,Nishimoto KP,Silk KM,Majumdar AS,Dawes GN,Waldmann H,Fairchild PJ,Lebkowski JS,Reddy A

    更新日期:2009-07-01 00:00:00

  • Graft and host interactions following transplantation of neural stem cells to organotypic striatal cultures.

    abstract:AIMS:To investigate neural stem cell (NSC) interactions with striatal tissue following engraftment and the effects of growth factors. MATERIALS & METHODS:Organotypic striatal slice cultures established from neonatal rats were used as an ex vivo model system. Survival, integration and differentiation of grafted NSCs fr...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.10.80

    authors: Jäderstad LM,Jäderstad J,Herlenius E

    更新日期:2010-11-01 00:00:00

  • Clinical use of autologous micro-fragmented fat progressively restores pain and function in shoulder osteoarthritis.

    abstract::Aim: We aim to show that the use of nondigested micro-fragmented adipose tissue (MFat™, Lipogems®) is a viable alternative for treatment of joint pain and inflammation associated dysfunction in shoulder osteoarthritis (OA). Materials & methods: A total of 25 subjects with OA received an injection of MFat™ and were fol...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0069

    authors: Vinet-Jones H,F Darr K

    更新日期:2020-10-01 00:00:00

  • Modeling biological and economic uncertainty on cell therapy manufacturing: the choice of culture media supplementation.

    abstract:AIM:To evaluate the cost-effectiveness of autologous cell therapy manufacturing in xeno-free conditions. MATERIALS & METHODS:Published data on the isolation and expansion of mesenchymal stem/stromal cells introduced donor, multipassage and culture media variability on cell yields and process times on adherent culture ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0034

    authors: Bandeiras C,Cabral JM,Finkelstein SN,Ferreira FC

    更新日期:2018-12-01 00:00:00

  • Conference Report: 6th Annual International Symposium on Regenerative Rehabilitation.

    abstract::The 6th International Symposium on Regenerative Rehabilitation, hosted by the Alliance for Regenerative Rehabilitation Research and Training (AR3T), included a preconference meeting of institutional representatives of the International Consortium of Regenerative Rehabilitation, keynote talks from distinguished scienti...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0026

    authors: Loghmani MT,Roche JA

    更新日期:2018-06-01 00:00:00

  • Tendon and ligament engineering: from cell biology to in vivo application.

    abstract::Tendons and ligaments are related connective tissues that join muscle to bone and bone to bone, respectively. Tendon and ligament injuries are widely distributed clinical problems in society and while healing of such disorders can occur, the original biological properties of the tissue do not return to normal. In this...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.1.4.563

    authors: Hoffmann A,Gross G

    更新日期:2006-07-01 00:00:00

  • Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development.

    abstract::A major challenge to commercializing cell-based therapies is developing scalable manufacturing processes while maintaining the critical quality parameters (identity, potency, purity, safety) of the final live cell product. Process development activities such as extended passaging and serum reduction/elimination can fa...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.11.105

    authors: Carmen J,Burger SR,McCaman M,Rowley JA

    更新日期:2012-01-01 00:00:00

  • The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics.

    abstract:AIM:This paper aims to map the trends and analyze key institutional dynamics that constitute the policies for reimbursement of regenerative medicine (RM), especially in the UK. MATERIALS & METHODS:Two quantitative publications studies using Google Scholar and a qualitative study based on a larger study of 43 semi-stru...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0041

    authors: Mahalatchimy A,Faulkner A

    更新日期:2017-09-01 00:00:00

  • Cell-based therapy approaches: the hope for incurable diseases.

    abstract::Cell therapies aim to repair the mechanisms underlying disease initiation and progression, achieved through trophic effect or by cell replacement. Multiple cell types can be utilized in such therapies, including stem, progenitor or primary cells. This review covers the current state of cell therapies designed for the ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.14.35

    authors: Buzhor E,Leshansky L,Blumenthal J,Barash H,Warshawsky D,Mazor Y,Shtrichman R

    更新日期:2014-01-01 00:00:00

  • Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?

    abstract::Dimethyl sulfoxide (DMSO) is the cryoprotectant of choice for most animal cell systems since the early history of cryopreservation. It has been used for decades in many thousands of cell transplants. These treatments would not have taken place without suitable sources of DMSO that enabled stable and safe storage of bo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0145

    authors: Awan M,Buriak I,Fleck R,Fuller B,Goltsev A,Kerby J,Lowdell M,Mericka P,Petrenko A,Petrenko Y,Rogulska O,Stolzing A,Stacey GN

    更新日期:2020-03-01 00:00:00

  • Organization profile: genetics policy institute.

    abstract::Genetics Policy Institute (GPI) is a nonprofit, public interest organization recognized as a leading promoter and defender of stem cell research and other cutting-edge medical research targeting cures. Since GPI's inception in 2003, its mission has focused on establishing a positive policy, regulatory and societal fra...

    journal_title:Regenerative medicine

    pub_type: 新闻

    doi:10.2217/rme.09.6

    authors: Siegel B

    更新日期:2009-05-01 00:00:00

  • Reliable assessment of bone marrow and bone marrow concentrates using automated hematology analyzer.

    abstract::Aim: A limiting factor in advancement of bone marrow based cell therapies is the lack of characterization of cell products delivered to patients. Methods: Using an automated hematology analyzer that can be implemented in clinical setting, the composition of bone marrow aspirates (n = 17 patients) and bone marrow conce...

    journal_title:Regenerative medicine

    pub_type: 临床试验,杂志文章

    doi:10.2217/rme-2018-0173

    authors: Mantripragada VP,Piuzzi NS,George J,Bova W,Ng M,Boehm C,Muschler GF

    更新日期:2019-07-01 00:00:00

  • Cell therapy for spinal cord injury informed by electromagnetic waves.

    abstract::Spinal cord injury devastates the CNS, besetting patients with symptoms including but not limited to: paralysis, autonomic nervous dysfunction, pain disorders and depression. Despite the identification of several molecular and genetic factors, a reliable regenerative therapy has yet to be produced for this terminal di...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0019

    authors: Finnegan J,Ye H

    更新日期:2016-10-01 00:00:00

  • Short-term outcomes after pure bone marrow aspirate injection for severe knee osteoarthritis: a case series.

    abstract::Background: Bone marrow aspiration (BMA) is among a group of autologous cell-based therapies currently being explored to treat osteoarthritis (OA). Materials & methods: This retrospective case study observed ten patients (13 knees) with severe knee OA who failed extensive conservative treatment and were treated with B...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0113

    authors: Colberg RE,Jurado Vélez JA,Walsh KP,Fleisig G

    更新日期:2020-07-01 00:00:00

  • Biochemical characterization of pure dehydrated binate amniotic membrane: role of cytokines in the spotlight.

    abstract:AIM:Placental allografts used for tissue regeneration differ in membrane compositions and processing techniques. A uniquely folded dehydrated binate amniotic membrane (DBAM) was biochemically characterized to evaluate its potential role in wound healing. METHODS:Histology, Luminex-based immunoassay and standard in vit...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0085

    authors: Sane MS,Misra N,Quintanar NM,Jones CD,Mustafi SB

    更新日期:2018-09-01 00:00:00

  • The long and winding road that leads to a cure for epidermolysis bullosa.

    abstract::Inherited epidermolysis bullosa (EB) is a family of rare genetic skin disorders characterized by structural and mechanical fragility of skin and mucosal membranes. The main feature of EB is the presence of recurrent skin blistering or erosions, which have a profound impact in the quality of life of EB patients and, in...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.33

    authors: Carulli S,Contin R,De Rosa L,Pellegrini G,De Luca M

    更新日期:2013-07-01 00:00:00

  • Regulatory requirements in the good manufacturing practice production of an epithelial cell graft for ocular surface reconstruction.

    abstract::In the past decade, stem cell therapy has been increasingly employed for the treatment of various diseases. Subsequently, there has been a great interest in the manufacture of stem cells under good manufacturing practice, which is required by law for their use in humans. The cells for sight Stem Cell Therapy Research ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2015-0020

    authors: Sheth-Shah R,Vernon AJ,Seetharaman S,Neale MH,Daniels JT

    更新日期:2016-04-01 00:00:00

  • The UK Stem Cell Bank: a UK government-funded, international resource center for stem cell research.

    abstract::The UK Stem Cell Bank is a UK Research Council-funded initiative that aims to provide ethically sourced and quality controlled stocks of cells for researchers and also establish seed stocks of cell lines for clinical trials. Whilst the Bank is prohibited from carrying out basic stem cell research (to avoid conflicts o...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.1.1.139

    authors: Stacey G,Hunt CJ

    更新日期:2006-01-01 00:00:00

  • The issue of immunology in stem cell therapies: a pharmaceutical perspective.

    abstract::Cautious approaches in the clinic are currently proposed, supported by relevant in vitro, in vivo and published data. Key to developing our understanding of the risks of immune rejection of stem cell based therapies will be the inclusion of immunological endpoints in clinical trials and the sharing of data. There is l...

    journal_title:Regenerative medicine

    pub_type: 社论

    doi:10.2217/rme.14.50

    authors: Haworth R,Sharpe M

    更新日期:2015-01-01 00:00:00